Toronto Dominion Bank Biogen Inc. Transaction History

Toronto Dominion Bank

$61.6 Billion
Q2 2024

A detailed history of Toronto Dominion Bank transactions in Biogen Inc. stock. As of the latest transaction made, Toronto Dominion Bank holds 83,248 shares of BIIB stock, worth $15.9 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

83,248

Previous 95,684 13.0%

Holding current value

$15.9 Million

Previous $20.6 Million 6.47%

% of portfolio

0.03%

Previous 0.03%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $2.37 Million - $2.94 Million	-12,436 Reduced 13.0%	83,248 $19.3 Million
Q1 2024 May 14, 2024	BUY	$212.02 - $267.71 $730,196 - $921,993	3,444 Added 3.73%	95,684 $20.6 Million
Q4 2023 Feb 13, 2024	BUY	$222.59 - $267.94 $259,094 - $311,882	1,164 Added 1.28%	92,240 $23.9 Million
Q3 2023 Feb 14, 2024	SELL	$253.3 - $285.89 $1.46 Million - $1.65 Million	-5,762 Reduced 5.95%	91,076 $23.4 Million
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $1.46 Million - $1.65 Million	-5,762 Reduced 5.95%	91,076 $23.4 Million
Q2 2023 Feb 14, 2024	BUY	$275.25 - $318.06 $1.27 Million - $1.46 Million	4,598 Added 4.98%	96,838 $27.6 Million
Q2 2023 Aug 10, 2023	BUY	$275.25 - $318.06 $333,603 - $385,488	1,212 Added 1.27%	96,838 $27.6 Million
Q1 2023 May 11, 2023	SELL	$256.56 - $292.34 $10.4 Million - $11.8 Million	-40,487 Reduced 29.75%	95,626 $26.6 Million
Q4 2022 Feb 07, 2023	BUY	$252.44 - $306.72 $14.3 Million - $17.4 Million	56,845 Added 71.71%	136,113 $37.7 Million
Q3 2022 Nov 09, 2022	SELL	$194.69 - $268.46 $2.84 Million - $3.92 Million	-14,592 Reduced 15.55%	79,268 $21.1 Million
Q2 2022 Aug 11, 2022	SELL	$187.54 - $223.02 $1.51 Million - $1.79 Million	-8,038 Reduced 7.89%	93,860 $19.1 Million
Q1 2022 May 09, 2022	SELL	$193.77 - $244.14 $3.37 Million - $4.24 Million	-17,369 Reduced 14.56%	101,898 $21.5 Million
Q4 2021 Feb 04, 2022	BUY	$223.92 - $287.77 $2.41 Million - $3.09 Million	10,743 Added 9.9%	119,267 $28.6 Million
Q3 2021 Nov 08, 2021	BUY	$282.99 - $369.05 $6.22 Million - $8.12 Million	21,991 Added 25.41%	108,524 $30.7 Million
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $22.4 Million - $35.9 Million	86,533 New	86,533 $30 Million

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $27.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

News

Stay updated on Toronto Dominion Bank with notifications on news.

Account

Toronto Dominion Bank Biogen Inc. Transaction History